YIH
PHAT icon

Y-Intercept (HK)’s Phathom Pharmaceuticals PHAT Stock Holding History

Y-Intercept (HK)’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$432K Buy
+39,845
New +$455K 0.01% 1353
2026
Q1 		– Sell
-30,488
Closed -$506K – 1936
2025
Q4 		$506K Buy
+30,488
New +$435K 0.01% 1234

Other funds holding PHAT

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Y-Intercept (HK)'s PHAT Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Phathom Pharmaceuticals (PHAT) in Q2 2026: 39,845 shares worth $432K. The stake represents 0.01% of the portfolio and ranks #1353 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in PHAT as recently as Q4 2025.

Y-Intercept (HK) first reported a position in PHAT in Q4 2025 and has held it in 2 quarters since. The position peaked at $506K in Q4 2025. 162 funds tracked by Wall St. Rank hold PHAT as of Q2 2026.

  • Y-Intercept (HK) held 39,845 shares of Phathom Pharmaceuticals worth $432K as of Q2 2026.
  • Phathom Pharmaceuticals was a new Y-Intercept (HK) position in Q2 2026.
  • Phathom Pharmaceuticals made up 0.01% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1353 holding.
  • Y-Intercept (HK) first reported a position in Phathom Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • Y-Intercept (HK)'s Phathom Pharmaceuticals position peaked at $506K in Q4 2025.
  • 162 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.